SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-21-062736
Filing Date
2021-05-07
Accepted
2021-05-07 07:00:43
Documents
55
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tm2113800d1_10q.htm 10-Q 652488
2 EXHIBIT 10.1 tm2113800d1_ex10-1.htm EX-10.1 102276
3 EXHIBIT 31.1 tm2113800d1_ex31-1.htm EX-31.1 10489
4 EXHIBIT 31.2 tm2113800d1_ex31-2.htm EX-31.2 10463
5 EXHIBIT 32.1 tm2113800d1_ex32-1.htm EX-32.1 6882
6 GRAPHIC tm2113800d1_img001.jpg GRAPHIC 43933
  Complete submission text file 0001104659-21-062736.txt   3551567

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT tril-20210331.xml EX-101.INS 586637
8 XBRL TAXONOMY EXTENSION SCHEMA tril-20210331.xsd EX-101.SCH 36803
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE tril-20210331_cal.xml EX-101.CAL 36322
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE tril-20210331_def.xml EX-101.DEF 136233
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE tril-20210331_lab.xml EX-101.LAB 332257
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tril-20210331_pre.xml EX-101.PRE 248902
Mailing Address 2488 DUNWIN DRIVE MISSISSAUGA A6 L5L 1J9
Business Address 2488 DUNWIN DRIVE MISSISSAUGA A6 L5L 1J9 (416) 595-0627
Trillium Therapeutics Inc. (Filer) CIK: 0001616212 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36596 | Film No.: 21900180
SIC: 2834 Pharmaceutical Preparations